Unknown

Dataset Information

Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability.


ABSTRACT: The foundation of a biosimilar manufacturer's regulatory filing is the demonstration of analytical and functional similarity between the biosimilar product and the pertinent originator product. The excipients in the formulation may interfere with characterization using typical analytical and functional techniques during this biosimilarity exercise. Consequently, the producers of biosimilar products resort to buffer exchange to isolate the biotherapeutic protein from the drug product formulation. However, the impact that this isolation has on the product stability is not completely known. This study aims to elucidate the extent to which mAb isolation via ultrafiltration-diafiltration-based buffer exchange impacts mAb stability. It has been demonstrated that repeated extraction cycles do res

SUBMITTER: Sarin D 

PROVIDER: S-EPMC10988557 | biostudies-literature | 2024 Apr

REPOSITORIES: biostudies-literature